Internship

NGS Data Analysis Optimization – Intern

Posted on 5/3/2024

Metagenomi

Metagenomi

201-500 employees

Develops genome editing tools for therapeutics

AI & Machine Learning
Biotechnology
Healthcare

Oakland, CA, USA

The internship is onsite in Emeryville, California for eight weeks from June 24, 2024, to August 16, 2024, with working hours from 9 am to 5 pm PST.

Category
Data Science
Data Analysis
Data & Analytics
Required Skills
Python
R
AWS
Data Analysis

You match the following Metagenomi's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Education: Actively pursuing a degree in Bioinformatics, Computational Biology, Biostatistics or a related field.
  • Strong understanding of NGS data formats and analysis concepts.
  • Proven scripting and data analysis skills (Python, R).
  • Familiarity with biological databases (gnomAD, Ensembl) and analysis tools (vep).
  • Experience with machine learning techniques.
  • Knowledge of cloud computing platforms (AWS).
Responsibilities
  • Optimize existing NGS workflows and identify areas for algorithm improvements.
  • Implement and test new bioinformatics tools or refine existing ones for enhanced data analysis.
  • Prototype an AI solution or statistical method using our large in house NGS datasets.

Metagenomi focuses on developing new genome editing tools for genetic medicine. The company explores natural environments to find undiscovered genetic material, which is then sequenced and engineered into potential therapeutics. By utilizing artificial intelligence and high-throughput screening, Metagenomi can quickly analyze billions of proteins to identify effective genome editing tools. This approach sets them apart from competitors who may rely on more traditional methods of discovery. The goal of Metagenomi is to create curative treatments for diseases through advanced gene editing techniques, ultimately benefiting healthcare providers and patients.

Company Stage

IPO

Total Funding

$366.1M

Headquarters

Emeryville, California

Founded

2016

Growth & Insights
Headcount

6 month growth

-1%

1 year growth

0%

2 year growth

13%
Simplify Jobs

Simplify's Take

What believers are saying

  • Increased interest in metagenomics is driving investment in companies like Metagenomi.
  • The trend towards personalized medicine boosts demand for precise genome editing tools.
  • Metagenomi's partnership with Ionis could potentially lead to a $3 billion deal.

What critics are saying

  • Class action lawsuits could lead to financial liabilities and damage Metagenomi's reputation.
  • The termination of the Moderna partnership may impact Metagenomi's financial projections.
  • Lack of clinical-stage candidates contributed to a 31% drop in Metagenomi's stock price.

What makes Metagenomi unique

  • Metagenomi uses metagenomics and AI to discover novel genome editing systems.
  • The company sources genetic material from unexplored natural environments for unique discoveries.
  • Metagenomi's gene editing systems are ultra-small, efficient, and have reduced immune response risks.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

401(k) Company Match

Performance Bonus

Stock Options

INACTIVE